InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,411.97
(
-1.66%
)
US TECH 100
18,007.60
(
-2.35%
)
Dow Jones
40,361.30
(
-0.97%
)
Brent Oil
70.99
(
-2.45%
)
Bitcoin
54,038.39
(
-3.79%
)
Post# of 10321
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BottomBounce

Send PM Follow Ignore
Followers 897
Posts 149153
Boards Moderated 0
Alias Born 08/13/2010

BottomBounce

Re: AdamS007 post# 5743

Monday, 11/30/2020 9:26:14 AM

Monday, November 30, 2020 9:26:14 AM

Post# of 10321
BCRX global phase 3 APeX. Trial-met-primary-endpoint of a reduction in the rate of HAE attacks for berotralstat 150 mg compared to placebo during the 24-week period (p=0.003). Berotralstat was safe and generally well-tolerated in the trial. https://finance.yahoo.com/news/allergy-publishes-results-biocryst-apex-120000777.html

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up